Pathophysiology, assessment and treatment of psoriatic dactylitis

被引:63
作者
McGonagle, Dennis [1 ,2 ]
Tan, Ai Lyn [1 ,2 ]
Watad, Abdulla [2 ,3 ,4 ]
Helliwell, Philip [2 ,5 ]
机构
[1] Chapel Allerton Hosp, INIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[3] Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Dept Med B, Ramat Gan, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Bradford Hosp NHS Fdn Trust, Rheumatol Dept, Bradford, W Yorkshire, England
关键词
PLACEBO-CONTROLLED TRIAL; TREATMENT RECOMMENDATIONS; CLASSIFICATION CRITERIA; INADEQUATE RESPONSE; DOUBLE-BLIND; ARTHRITIS; DISEASE; SPONDYLOARTHRITIS; EFFICACY; THERAPY;
D O I
10.1038/s41584-018-0147-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dactylitis is diffuse swelling of the digits that is usually related to an underlying inflammatory or infiltrative disorder. Psoriatic arthritis (PsA) is the most common severe disease thought to cause dactylitis. Our understanding of the pathogenesis of PsA-related dactylitis comes from experimental animal models of PsA-like disease, as well as advances in imaging and other clinical studies. Clinical trials in PsA have increasingly included dactylitis as an important secondary outcome measure. These studies indicate that cytokines drive multi-locus microanatomical pan-digital pathology. Given the importance of pro-inflammatory cytokines, the pathogenesis of dactylitis is best understood as an initial aberrant innate immune response to biomechanical stress or injury, with subsequent adaptive immune mechanisms amplifying the dactylitis inflammatory response. Regarding the treatment of dactylitis, no studies have been conducted using dactylitis as the primary outcome measure, and the current knowledge comes from analysis of dactylitis as a secondary outcome measure.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 86 条
[1]   Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [J].
Antoni, CE ;
Kavanagh, A ;
Kirkham, B ;
Tutuncu, Z ;
Burmester, GR ;
Schneider, U ;
Furst, DE ;
Molitor, J ;
Keystone, E ;
Gladman, D ;
Manger, B ;
Wassenberg, S ;
Weier, R ;
Wallace, DJ ;
Weisman, MH ;
Kalden, JR ;
Smolen, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1227-1236
[2]  
Antoni CE, 2008, J RHEUMATOL, V35, P869
[3]   Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study [J].
Baranauskaite, Asta ;
Raffayova, Helena ;
Kungurov, N. V. ;
Kubanova, Anna ;
Venalis, Algirdas ;
Helmle, Laszlo ;
Srinivasan, Shankar ;
Nasonov, Evgeny ;
Vastesaeger, Nathan .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) :541-548
[4]   Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice [J].
Benham, Helen ;
Rehaume, Linda M. ;
Hasnain, Sumaira Z. ;
Velasco, Jared ;
Baillet, Athan C. ;
Ruutu, Merja ;
Kikly, Kristine ;
Wang, Ran ;
Tseng, Hsu-Wen ;
Thomas, Gethin P. ;
Brown, Matthew A. ;
Strutton, Geoffrey ;
McGuckin, Michael A. ;
Thomas, Ranjeny .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (07) :1755-1767
[5]   The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites [J].
Benjamin, M ;
McGonagle, D .
JOURNAL OF ANATOMY, 2001, 199 :503-526
[6]   Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in "stress-induced arthritis" [J].
Braem, Kirsten ;
Carter, Shea ;
Lories, Rik J. .
BIOLOGICAL PROCEDURES ONLINE, 2012, 14
[7]   Characterisation of hand small joints arthropathy using high-resolution MRI-Limited discrimination between osteoarthritis and psoriatic arthritis [J].
Braum, Leonie S. ;
McGonagle, Dennis ;
Bruns, Anne ;
Philipp, Sandra ;
Hermann, Sandra ;
Aupperle, Karlfried ;
Tan, Ai Lyn ;
Diekhoff, Torsten ;
Hamm, Bernd ;
Hermann, Kay-Geert A. .
EUROPEAN RADIOLOGY, 2013, 23 (06) :1686-1693
[8]   Dactylitis in psoriatic arthritis: a marker for disease severity? [J].
Brockbank, JE ;
Stein, M ;
Schentag, CT ;
Gladman, DD .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :188-190
[9]   Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis [J].
Carron, Philippe ;
Lambert, Bieke ;
Van Praet, Liesbet ;
De Vos, Filip ;
Varkas, Gaelle ;
Jans, Lennart ;
Elewaut, Dirk ;
Van den Bosch, Filip .
RMD OPEN, 2016, 2 (01)
[10]   International Multicenter Psoriasis and Psoriatic Arthritis Reliability Trial for the Assessment of Skin, Joints, Nails, and Dactylitis [J].
Chandran, Vinod ;
Gottlieb, Alice ;
Cook, Richard J. ;
Duffin, Kristina Callis ;
Garg, Amit ;
Helliwell, Philip ;
Kavanaugh, Arthur ;
Krueger, Gerald G. ;
Langley, Richard G. ;
Lynde, Charles ;
McHugh, Neil ;
Mease, Philip ;
Olivieri, Ignazio ;
Rahman, Proton ;
Rosen, Cheryl F. ;
Salvarani, Carlo ;
Thaci, Diamant ;
Toloza, Sergio M. A. ;
Wong, Maxine Yat Wing ;
Zhou, Qian M. ;
Gladman, Dafna D. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09) :1235-1242